Life Sciences

FDA Sets Tougher Approval Criteria for Covid Booster Sh...

The Food and Drug Administration (FDA) has introduced more rigorous regulatory r...

Boehringer’s Nerandomilast Advances in IPF Amid Analyst...

Boehringer Ingelheim’s presentation of phase 3 data for its idiopathic pulmonary...

CellCentric Secures $120M Series C Funding to Advance M...

CellCentric, a UK-based biotechnology company backed by Pfizer, has raised $120 ...

Scientists Identify New Target to Prevent Cancer from S...

In a major breakthrough, researchers have uncovered a potential way to stop canc...

Moderna Delays Flu-COVID Combo Vaccine Filing Amid FDA ...

Moderna has announced that it is withdrawing its application for approval from t...

Pathos AI Secures $365 Million in Series D Funding to A...

Pathos AI, a clinical-stage biotech company leveraging artificial intelligence t...

FDA Delays Biohaven’s Approval Decision for Rare Diseas...

The U.S. Food and Drug Administration (FDA) has postponed its decision on Biohav...

FDA Clears First At-Home HPV and Cervical Cancer Screen...

The U.S. Food and Drug Administration has approved the first at-home collection ...

Eli Lilly Invests $250 Million to Strengthen Ties with ...

Eli Lilly is deepening its investment in Indiana by committing up to $250 millio...

FDA and CDC Recommend Halting Chikungunya Vaccine Use i...

Following similar actions by France and the European Union, U.S. health authorit...

Abeona Nets $155M in Voucher Sale After FDA Approval

Abeona Therapeutics has secured a $155 million deal from the sale of a Priority ...

J&J Gene Therapy Treatment For Vision Loss Fails to Mee...

Johnson & Johnson acquired the entire rights to a gene treatment for a rare cond...

New Data Positions Immutep’s Immunotherapy Combo as Fir...

Immutep, the developer of eftilagimod alpha, has reported promising overall surv...

Eli Lilly Secures Rights to Alchemab’s Early-Stage ALS ...

Just four months after announcing a research collaboration, Eli Lilly is licensi...

Vertex Presses Pause on CF Study, Reports Major Write-Down

Vertex Pharmaceuticals has announced a temporary pause in part of a clinical tri...

Medtronic Highlights Improved Results with Affera PFA T...

Medtronic has announced encouraging clinical outcomes from two studies evaluatin...